Rothfuss Cristin sold SRPT
November 28, 2025 · Form 4 insider transaction
Rothfuss Cristin sold 229 shares of Sarepta Therapeutics, Inc. at $21.12 per share, a transaction worth $4.8K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
229
Price
$21.12
Total value
$4.8K
InsiderRothfuss Cristin
RoleOfficer
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateNovember 28, 2025
Filing dateDecember 2, 2025
Shares owned after139,756
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on November 26, 2024.